TR200100769T2 - Yeni bir bileşim - Google Patents

Yeni bir bileşim

Info

Publication number: TR200100769T2
Authority: TR; Turkey
Prior art keywords: composition; compound component; mood disorders; new composition; disorders
Prior art date: 1998-09-16

Application number

TR2001/00769T

Other languages

English (en)

Turkish (tr)

Inventor

Evenden John

Thorberg Seth-Olov

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-16

Filing date

1999-09-13

Publication date

2001-11-21

1999-09-13 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2001-11-21 Publication of TR200100769T2 publication Critical patent/TR200100769T2/xx

Links

239000000203 mixture Substances 0.000 title abstract 4
208000019022 Mood disease Diseases 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 abstract 1
208000019901 Anxiety disease Diseases 0.000 abstract 1
FEWJPZIEWOKRBE-JCYAYHJZSA-L L-tartrate(2-) Chemical compound [O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-L 0.000 abstract 1
-1 butyl amino -8-fluoro -3,4-dihydro -2H-1-benzopyran -5-carboxamide Chemical compound 0.000 abstract 1
125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 abstract 1
239000012458 free base Substances 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

TR2001/00769T 1998-09-16 1999-09-13 Yeni bir bileşim TR200100769T2 (tr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE9803157A SE9803157D0 (sv)	1998-09-16	1998-09-16	A new composition

Publications (1)

Publication Number	Publication Date
TR200100769T2 true TR200100769T2 (tr)	2001-11-21

Family

ID=20412628

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TR2001/00769T TR200100769T2 (tr)	1998-09-16	1999-09-13	Yeni bir bileşim

Country Status (21)

Country	Link
EP (1)	EP1121119A1 (is)
JP (1)	JP2002524509A (is)
KR (1)	KR20010099648A (is)
CN (1)	CN1317963A (is)
AR (1)	AR023657A1 (is)
AU (1)	AU6378199A (is)
BR (1)	BR9913765A (is)
CA (1)	CA2342585A1 (is)
CZ (1)	CZ2001962A3 (is)
EE (1)	EE200100156A (is)
HU (1)	HUP0103569A3 (is)
ID (1)	ID28359A (is)
IL (1)	IL141520A0 (is)
IS (1)	IS5877A (is)
NO (1)	NO20011313L (is)
PL (1)	PL346769A1 (is)
SE (1)	SE9803157D0 (is)
SK (1)	SK3272001A3 (is)
TR (1)	TR200100769T2 (is)
WO (1)	WO2000015219A1 (is)
ZA (1)	ZA200101951B (is)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR021155A1 (es)	1999-07-08	2002-06-12	Lundbeck & Co As H	Tratamiento de desordenes neuroticos
DE60122015T2 (de)	2000-10-13	2006-11-23	Neurosearch A/S	Behandlung affektiver störungen durch kombinierte wirkung eines nikotinischen rezeptoragonisten und einer monoaminergischen substanz
WO2006038217A1 (en) *	2004-10-05	2006-04-13	Strides Acrolab Limited	An improved drug delivery system of citalopram hydrobromide and process for producing the same
US20110196032A1 (en)	2005-05-20	2011-08-11	Ashish Gogia	Pharmaceutical Dosage Form of an Antidepressant
TW200812993A (en) *	2006-05-02	2008-03-16	Lundbeck & Co As H	New uses of escitalopram

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9501567D0 (sv) *	1995-04-27	1995-04-27	Astra Ab	A new combination

1998
- 1998-09-16 SE SE9803157A patent/SE9803157D0/xx unknown
1999
- 1999-09-13 ID IDW20010580A patent/ID28359A/id unknown
- 1999-09-13 PL PL99346769A patent/PL346769A1/xx unknown
- 1999-09-13 CZ CZ2001962A patent/CZ2001962A3/cs unknown
- 1999-09-13 EE EEP200100156A patent/EE200100156A/xx unknown
- 1999-09-13 HU HU0103569A patent/HUP0103569A3/hu unknown
- 1999-09-13 TR TR2001/00769T patent/TR200100769T2/xx unknown
- 1999-09-13 EP EP99951320A patent/EP1121119A1/en not_active Withdrawn
- 1999-09-13 CA CA002342585A patent/CA2342585A1/en not_active Abandoned
- 1999-09-13 AU AU63781/99A patent/AU6378199A/en not_active Abandoned
- 1999-09-13 JP JP2000569803A patent/JP2002524509A/ja active Pending
- 1999-09-13 BR BR9913765-8A patent/BR9913765A/pt not_active Application Discontinuation
- 1999-09-13 KR KR1020017003338A patent/KR20010099648A/ko not_active Withdrawn
- 1999-09-13 SK SK327-2001A patent/SK3272001A3/sk unknown
- 1999-09-13 IL IL14152099A patent/IL141520A0/xx unknown
- 1999-09-13 CN CN99811007A patent/CN1317963A/zh active Pending
- 1999-09-13 WO PCT/SE1999/001598 patent/WO2000015219A1/en not_active Ceased
- 1999-09-15 AR ARP990104627A patent/AR023657A1/es unknown
2001
- 2001-03-05 IS IS5877A patent/IS5877A/is unknown
- 2001-03-08 ZA ZA200101951A patent/ZA200101951B/xx unknown
- 2001-03-15 NO NO20011313A patent/NO20011313L/no unknown

Also Published As

Publication number	Publication date
EP1121119A1 (en)	2001-08-08
EE200100156A (et)	2002-08-15
IL141520A0 (en)	2002-03-10
IS5877A (is)	2001-03-05
CN1317963A (zh)	2001-10-17
CA2342585A1 (en)	2000-03-23
WO2000015219A1 (en)	2000-03-23
SK3272001A3 (en)	2001-09-11
KR20010099648A (ko)	2001-11-09
AR023657A1 (es)	2002-09-04
CZ2001962A3 (cs)	2001-08-15
ID28359A (id)	2001-05-17
PL346769A1 (en)	2002-02-25
HUP0103569A2 (hu)	2002-02-28
NO20011313L (no)	2001-05-16
ZA200101951B (en)	2002-06-10
NO20011313D0 (no)	2001-03-15
AU6378199A (en)	2000-04-03
SE9803157D0 (sv)	1998-09-16
HUP0103569A3 (en)	2002-03-28
JP2002524509A (ja)	2002-08-06
BR9913765A (pt)	2001-06-05

Similar Documents

Publication	Publication Date	Title
SE9501567D0 (sv)	1995-04-27	A new combination
NO20034230L (no)	2003-09-23	1,2,3,4-tetrahydroisokinolin-derivater som urotensin II reseptor-antagonister
ATE496884T1 (de)	2011-02-15	Sulphonylaminoessigsaeure derivate und deren verwendung als orexin rezeptor antagoniste
SE0101675D0 (sv)	2001-05-11	Novel composition
NO20024339D0 (no)	2002-09-11	1,2,3,4-Tetrahydroisokinolin-derivater
YU40701A (sh)	2004-05-12	Piperidini kao modulatori ccr5
NO20042964L (no)	2004-09-07	Spiroazasykliske forbindelser som monoaminreseptormodulatorer
ATE380187T1 (de)	2007-12-15	Agonisten und antagonisten für den lpa-rezeptor und anwendungsmethoden
SE0300119D0 (sv)	2003-01-17	Novel compounds
NO20042844L (no)	2004-08-23	4-(piperidyl- og pyrrolidyl-alkyl-ureido)-kinoliner som uprotensin II reseptor-antagonister
TR200403020T2 (tr)	2005-05-23	(S)-4-Amino-5-kloro-2-metoksi-N- (1-(1-(2-tetrahidrofuril-carbonil)-4-piperidinylmetil) -4-piperidinil)benzamit, bunun hazırlama işlemi ve aynı formülü ve bunun ara mamülünü içeren farmasötik bileşim
FR2806299B1 (fr)	2002-12-20	Compositions pour la teinture des fibres keratiniques contenant des derives de paraphenylenediamine a groupement pyrrolidinyle
ATE479655T1 (de)	2010-09-15	Neue aminoazetidin-, aminopyrrolidin- und aminopiperidinderivative
BR0306980A (pt)	2004-11-09	Composto, uso de um composto, composição farmacêutica, e, método para o tratamento de distúrbios ou doenças relacionadas com o receptor de histamina h3
TR200000737T2 (tr)	2000-09-21	İkame edilmiş kroman türevleri.
PT1140031E (pt)	2004-03-31	Preparacao farmaceutica de libertacao controlada com mesilato de tilidina como substancia activa
EE200200591A (et)	2004-04-15	Püridiin-1-oksiidderivaat ja meetod selle muutmiseks farmatseutiliselt efektiivseteks ühenditeks
BR0211739A (pt)	2004-09-28	Novas formas polimórficas cristalinas de cloridrato de lercanidipina e processo para preparação das mesmas
ATE369348T1 (de)	2007-08-15	Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
NO20014855L (no)	2001-12-06	N-(2-fenyl-4-aminobutyl)-1-naftamider som neurokinin-1- reseptorantagonister
BR9916807A (pt)	2001-10-23	Antagonistas de 5ht1 para terapia antidepressiva
DE60225155D1 (de)	2008-04-03	3-substituierte 6,7-dihydroxytetrahydroisochinolin-derivate zur verwendung als antibkaterielle mittel
HRP20040360B1 (hr)	2013-02-28	Linearni baziäśni spojevi koji djeluju kao antagonisti nk2 i njihove formulacije
SE9904404L (sv)	2000-12-23	Ny komposition
SE9803157D0 (sv)	1998-09-16	A new composition